In TNBC, Pathologic Complete Response May Vary by Race/Ethnicity Compared with white women, Black women less likely and Hispanic women more likely to achieve pCR Feb 27, 2024
Mixed Results in Advanced Gastric/GEJ Cancer With Add-On Fruquintinib Significant improvement in PFS, but not OS, versus chemo alone in the second-line setting Feb 07, 2024
Patients and Doctors Push Back Against the Harsh Side Effects of Cancer Drugs "If the patients are not taking the drug, then it's not going to work" Feb 06, 2024
Sequential Therapy Boosts Survival in Metastatic Pancreatic Cancer Phase II study shows a 32% reduced risk of death compared with standard treatment Jan 31, 2024
Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer? Retrospective study suggests the technique results in fewer complications, thrombotic events Jan 30, 2024
When a Revolutionary Cancer Treatment Causes Cancer The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
Lessons From the Chemotherapy Shortages: Invest in Generics We need more sustainable solutions to ensure treatment access Dec 31, 2023
How Vital Drug Shortages Happen "Fundamentally, there's something broken in how the market works" Sep 11, 2023 video
Standard Lymphoma Therapies Tied to Higher Risk for New Malignancies Increased risk for non-melanoma skin cancer, MDS, AML versus the general population Sep 09, 2023
How the Chemotherapy Shortage Is Affecting Frontline Clinicians "How are we here in 2023 having some of these discussions?" bemoans gynecologic cancer expert Sep 08, 2023 video
Cancer Therapy's Lower-Limb Blood Clots Better Treated With Long Anticoagulation A year of DOAC therapy did not result in significantly more bleeds in ONCO DVT trial Aug 29, 2023
Some NSCLC Patients on ICI Therapy Fare Worse With Proton Pump Inhibitor Use But PFS, OS longer with ICIs plus chemotherapy among patients treated with PPIs Jul 11, 2023
Primary Surgery vs Radiation in Oropharyngeal Cancer: Does One Come Out a Winner? Higher short-term dysphagia risk with surgery, but RT/CRT had worse 5-year OS Jul 09, 2023
WHO Links Sweetener to Cancer; Younger-Age CRC Risk; PCOS and Ovarian Cancer News, features, and commentary about cancer-related issues Jun 29, 2023
New Ovarian Cancer Drug Extends Survival in Resistant Disease "Practice changing" findings for tough-to-treat patient population Jun 04, 2023
Chemo-Free Approach Works in Subset of Patients With HER2+ Early Breast Cancer Impressive 3-year invasive DFS seen with adaptive response strategy using FDG-PET Jun 03, 2023
Return of Rule Nixing Delivery of Rx Drugs to Medicare Patients Drawing Docs' Ire "It is endangering the lives of the oldest and sickest Americans," oncology group says May 18, 2023
Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer Small but clear boost to overall survival May 07, 2023
Implanted Ultrasound Device Opening Blood-Brain Barrier Promising in Brain Tumors Device allows delivery of more potent chemotherapies to patients with glioblastomas May 03, 2023
HIPEC With Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancer No increase in adverse events or toxicity versus surgery alone Apr 26, 2023
Manufacturer's Troponin Reference Values Don't Apply to Kids Different thresholds for myocardial injury suggested for pediatric patients Apr 21, 2023
Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrence Chemotherapy regimens with higher cumulative dose provide greatest benefit Apr 14, 2023
Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
Exercise During Chemo Shows Benefits for Cardiorespiratory Fitness However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
Treatment De-Escalation Shows Promise in Testicular Cancer Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
Study: U.S. Chemo Regimen for Ewing Sarcoma Should Be International Standard Europe and other countries have already followed suit Nov 01, 2022
Hand Cooling, Compression Both Effective for Nerve Pain in Breast Cancer But access, cost, and tolerability may favor the latter option, said researcher Sep 14, 2022
10-Year Follow-Up Confirms Benefit of Chemoradiotherapy in MIBC Patients Findings "supported a change in clinical practice" Sep 01, 2022
Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemo Ototoxicity reported in more than half of study patients who got platinum, taxanes, or both Aug 03, 2022
'Rogue' Online Pharmacies Are Dispensing Cancer Drugs Shady sites with little oversight are selling imatinib for much less than U.S. retail price Jul 29, 2022
Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
Liquid Biopsy May Save Colon Cancer Patients From Chemo Circulating tumor DNA could determine who needs more therapy Jun 06, 2022
Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphoma Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
Chemo-ICI Combo Promising in Soft Tissue Sarcoma PFS rate of 69% at 12 weeks in liposarcoma patients with eribulin and pembrolizumab Nov 14, 2021
The Cost of Blood Platelets Is About to Surge FDA's flawed new guidance for blood transfusion safety takes effect October 1 Sep 30, 2021
Improved DFS, but No OS Boost, With Chemo in CRC With Liver Metastases Longer disease-free survival did not mean longer overall survival for these patients Sep 28, 2021
Transarterial Radioembolization Slows Progression of CRC With Liver Mets Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
Androgen-Targeting Combos Show Promise in Prostate Cancer Trials extend survival in hormone-sensitive disease Sep 21, 2021
Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
